{"id":858930,"date":"2023-02-03T18:02:29","date_gmt":"2023-02-03T17:02:29","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/"},"modified":"2023-02-03T18:02:29","modified_gmt":"2023-02-03T17:02:29","slug":"neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/","title":{"rendered":"Neurent Medical Announces Limited Market Release of NEUROMARK\u00ae System to Treat Chronic Rhinitis"},"content":{"rendered":"NEUROMARK received new Category I CPT code and support from AAO position statement\n\nGALWAY, Ireland--(BUSINESS WIRE)--Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sino-nasal diseases, today announced its NEUROMARK\u00ae Rhinitis Neurolysis Therapy (RNT) is now commercially available in limited U.S. markets. Commercialization comes as the American Medical Association (AMA) issued a new Category I Current Procedural Terminology (CPT\u00ae) code for posterior nasal nerve ablation (PNN) procedures, which includes NEUROMARK, to treat chronic rhinitis. The code will go into effect in January 2024. Furthermore, the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) endorses this <div class=\"leaky_paywall_message_wrap\"><div id=\"leaky_paywall_message\"><a href=\"https:\/\/bebeez.it\/abbonati\/\">Abbonati<\/a> o <a href=\"https:\/\/bebeez.it\/mio-account\/\">Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>NEUROMARK received new Category I CPT code and support from AAO position statement GALWAY, Ireland&#8211;(BUSINESS WIRE)&#8211;Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sino-nasal diseases, today announced its NEUROMARK\u00ae Rhinitis Neurolysis Therapy (RNT) is now commercially available in limited U.S. markets. Commercialization comes as the American Medical Association (AMA) issued a [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-858930","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Neurent Medical Announces Limited Market Release of NEUROMARK\u00ae System to Treat Chronic Rhinitis - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neurent Medical Announces Limited Market Release of NEUROMARK\u00ae System to Treat Chronic Rhinitis - BeBeez\" \/>\n<meta property=\"og:description\" content=\"NEUROMARK received new Category I CPT code and support from AAO position statement GALWAY, Ireland--(BUSINESS WIRE)--Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sino-nasal diseases, today announced its NEUROMARK\u00ae Rhinitis Neurolysis Therapy (RNT) is now commercially available in limited U.S. markets. Commercialization comes as the American Medical Association (AMA) issued a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-03T17:02:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Neurent Medical Announces Limited Market Release of NEUROMARK\u00ae System to Treat Chronic Rhinitis\",\"datePublished\":\"2023-02-03T17:02:29+00:00\",\"dateModified\":\"2023-02-03T17:02:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/\"},\"wordCount\":461,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/\",\"name\":\"Neurent Medical Announces Limited Market Release of NEUROMARK\u00ae System to Treat Chronic Rhinitis - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2023-02-03T17:02:29+00:00\",\"dateModified\":\"2023-02-03T17:02:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neurent Medical Announces Limited Market Release of NEUROMARK\u00ae System to Treat Chronic Rhinitis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neurent Medical Announces Limited Market Release of NEUROMARK\u00ae System to Treat Chronic Rhinitis - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/","og_locale":"en_US","og_type":"article","og_title":"Neurent Medical Announces Limited Market Release of NEUROMARK\u00ae System to Treat Chronic Rhinitis - BeBeez","og_description":"NEUROMARK received new Category I CPT code and support from AAO position statement GALWAY, Ireland--(BUSINESS WIRE)--Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sino-nasal diseases, today announced its NEUROMARK\u00ae Rhinitis Neurolysis Therapy (RNT) is now commercially available in limited U.S. markets. Commercialization comes as the American Medical Association (AMA) issued a [&hellip;]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/","og_site_name":"BeBeez","article_published_time":"2023-02-03T17:02:29+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/"},"author":{"name":"","@id":""},"headline":"Neurent Medical Announces Limited Market Release of NEUROMARK\u00ae System to Treat Chronic Rhinitis","datePublished":"2023-02-03T17:02:29+00:00","dateModified":"2023-02-03T17:02:29+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/"},"wordCount":461,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/","name":"Neurent Medical Announces Limited Market Release of NEUROMARK\u00ae System to Treat Chronic Rhinitis - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2023-02-03T17:02:29+00:00","dateModified":"2023-02-03T17:02:29+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Neurent Medical Announces Limited Market Release of NEUROMARK\u00ae System to Treat Chronic Rhinitis"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/858930","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=858930"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/858930\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=858930"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=858930"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=858930"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=858930"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=858930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}